Patient Capital Management LLC Raises Stock Holdings in UnitedHealth Group Incorporated $UNH

Patient Capital Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 93.5% during the third quarter, HoldingsChannel.com reports. The firm owned 371,363 shares of the healthcare conglomerate’s stock after purchasing an additional 179,431 shares during the period. UnitedHealth Group makes up approximately 5.1% of Patient Capital Management LLC’s portfolio, making the stock its 3rd biggest holding. Patient Capital Management LLC’s holdings in UnitedHealth Group were worth $128,232,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Exchange Traded Concepts LLC raised its holdings in UnitedHealth Group by 48.0% during the 2nd quarter. Exchange Traded Concepts LLC now owns 4,184 shares of the healthcare conglomerate’s stock worth $1,305,000 after purchasing an additional 1,357 shares during the last quarter. Ridgewood Investments LLC raised its stake in UnitedHealth Group by 322.3% during the second quarter. Ridgewood Investments LLC now owns 511 shares of the healthcare conglomerate’s stock worth $159,000 after buying an additional 390 shares during the last quarter. Finally, Farmers Trust Co. raised its position in shares of UnitedHealth Group by 42.4% in the 2nd quarter. Farmers Trust Co. now owns 2,129 shares of the healthcare conglomerate’s stock worth $664,000 after acquiring an additional 634 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $338.47 on Wednesday. The company’s 50 day moving average price is $330.76 and its two-hundred day moving average price is $322.56. The stock has a market cap of $306.60 billion, a P/E ratio of 17.67, a P/E/G ratio of 2.00 and a beta of 0.42. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue was up 12.2% compared to the same quarter last year. During the same period last year, the firm posted $7.15 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s payout ratio is 46.14%.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a research note on Wednesday, October 29th. Jefferies Financial Group upped their price target on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. Finally, Sanford C. Bernstein increased their target price on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $385.75.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.